The TCR phosphorylation is the first signaling event in T cells to elicit adaptive immunity against tumor cells.[42, 43, 44] These findings indicate that the K‐TM triggers CD8+ T cell anergy and tumor immune evasion by targeting the coreceptor CD3ε and blocking TCR signaling. The gene discussed is CD3E; the disease is neoplasm.